Tuesday 17th June 2014 |
Text too small? |
Facebook New Zealand, the local service unit of the global social media website, said sales rose 7.4 percent last year, lagging behind an 11 percent gain in expenses and resulting in a wider annual loss.
Sales rose to $846,391 in calendar 2013, from $787,830 in 2012, according to the company's annual report. All of the revenue came from Facebook Ireland under a service agreement and is unlikely to reflect the ultimate parent Facebook’s advertising sales in New Zealand. The net loss widened to $82,810 from $59,313. Income tax paid in New Zealand was $23,034, down from $28,484 in 2012.
A spokesman for the New Zealand business wasn't immediately available. Facebook maintains an office in Auckland, though it doesn't have a phone listing in the White Pages. Two employees are listed as having received restricted ordinary shares under the company's stock incentive plan while employee benefits expense rose 8.2 percent last year to $547,409.
Sales for the local unit are a drop in the ocean for Nasdaq-listed Facebook, which generated revenue of US$2.5 billion in the first quarter, up 72 percent from a year earlier. About 91 percent of revenue, or US$2.27 billion, came from advertising, while payments and other fees revenue generated US$237 million.
Facebook stock has soared 167 percent in the past 12 months, outpacing an 18 percent gain in the Standard & Poor's 500 Index and valuing the company at about US$165 billion. The shares are rated a 'buy' by analysts polled by Reuters. The company's 2012 IPO valued Facebook at US$104 billion, making it the largest-ever such valuation for a newly listed public company.
According to the Careers at Facebook website, the company doesn't have any jobs available in New Zealand, although it has one, a client solutions manager on contract, on offer in Sydney.
Facebook’s registered office in New Zealand is given as law firm Kensington Swan in Wellington.
BusinessDesk.co.nz
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors